Datasets:

Ichlibitiche
/

csa-clinical-stage-asset-intelligence-sample

license: cc-by-nc-4.0
pretty_name: CSA — Clinical-Stage Asset Intelligence (Free Sample)
task_categories:
  - tabular-classification
tags:
  - biotech
  - clinical-trials
  - finance
  - pharmaceuticals
  - catalyst-calendar
  - healthcare
size_categories:
  - n<1K
configs:
  - config_name: catalyst_calendar
    data_files: catalyst_calendar_sample.csv
    default: true
  - config_name: asset_master
    data_files: asset_master_sample.csv

CSA — Clinical-Stage Asset Intelligence · Free Sample

Clinical trials, FDA, and SEC — linked to the drug asset and the listed sponsor, with a forward catalyst calendar. This is a free 150-row sample of the nearest-term catalysts; the full snapshot carries 2,103 forward catalysts across 139 listed sponsors and 1,841 resolved assets.

Data, not investment advice. CSA is information, not a recommendation to buy, sell, or hold any security. Estimated catalyst dates (e.g. protocol primary-completion dates) routinely slip and are graded by confidence — verify anything material against the source_url on each row.

What's inside

File	Rows	What it is
`catalyst_calendar_sample.csv`	150	Nearest-term forward catalysts (2026-07-18 → 2027-09-01), 108 assets, 50 sponsors.
`asset_master_sample.csv`	464	The asset ↔ trial ↔ sponsor ↔ ticker rows behind them.
`*_sample.json`	—	The same tables as records-oriented JSON.

`catalyst_calendar_sample.csv`

event_date · ticker · asset · event_type (PDUFA / READOUT / …) · event_window · date_precision · confidence · source (sec_8k / clinicaltrials) · nct_id · source_url.

`asset_master_sample.csv`

asset · nct_id · phase · status · primary_completion · conditions · arm_role · sponsor_raw · company_name · ticker.

How it's built

Active-moiety resolution keys each asset to its FDA-registered UNII set (GSRS), not fuzzy names — audited to zero cross-molecule merges.
Sponsor → listed ticker through acquisitions, to the primary US listing.
Dual-channel catalysts: SEC 8-K disclosure text + active late-phase ClinicalTrials.gov protocol readouts. Every row carries its source.

Sample scope: active, industry-sponsored, Phase 3 trials in cardiometabolic, oncology and immunology. Asset names are normalized for readability; the sample is curated to clinical-stage, single-sponsor assets.

Sources & license

All primary sources are U.S. Government / public domain: ClinicalTrials.gov, openFDA, SEC EDGAR, GSRS/UNII. This sample is released under CC-BY-NC-4.0 (free to use and share with attribution, not to re-sell). See SAMPLE_LICENSE.md.

Get the full dataset

The complete, commercially-licensed snapshot (all 2,103 catalysts, CSV + JSON, monthly editions + delta feed) → https://csa.dataengineered.io · code: https://github.com/CSA-pub/CSA-public · contact: https://csa.dataengineered.io/#contact